Laurie J. Olson - 07 Jun 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Jun 2021
Net transactions value
-$112,280
Form type
4
Filing time
07 Jun 2021, 17:51:50 UTC
Next filing
23 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $339,440 +4,000 $84.86 4,000 07 Jun 2021 Direct
transaction KRTX Common Stock Sale $451,720 -4,000 -100% $112.93 0 07 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -4,000 -16% $0.000000 21,000 07 Jun 2021 Common Stock 4,000 $84.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.